Disease Progression  >>  Urocidin (mycobacterium cell wall-DNA complex)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Urocidin (mycobacterium cell wall-DNA complex) / Liminal BioSci
NCT01284205: First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Withdrawn
3
0
US
Mycobacterial Cell-Wall DNA Complex, Bacillus Calmette-Guerin
Bioniche Life Sciences Inc.
Bladder Cancer
02/14
02/17
NCT00406068: Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Completed
2/3
129
US, Canada
Mycobacterial cell wall-DNA complex, MCC - Urocidin
Bioniche Life Sciences Inc.
Bladder Neoplasms
07/11
07/11

Download Options